Fundraising Fox

GC Therapeutics

Cambridge, US · 3 known investors

gc-tx.com ↗

GCTx develops an induced pluripotent stem cell (iPSC) programming platform called TFome™ that uses synthetic biology, gene editing, and machine learning to improve cell therapy development and scaling. The platform is designed to expand patient access to cell therapies across various therapeutic areas.

AI & Machine LearningBiotechMedical Devicesin /gctx@GCTherapeutics

Founders & leadership

GC
George ChurchCo-Founder & Scientific Advisor
PK
Parastoo KhoshakhlaghChief Executive Officer & Co-Founder
AN
Alex NgChief Innovation Officer & Co-Founder

Investors · 3

Andreessen HorowitzMenlo Park
Global Brain$100K
Medical Excellence Capital

In the news